Cargando…

Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance

BACKGROUND: Enterococci are frequent pathogens causing nosocomial infections in Germany. Infections due to strains with vancomycin resistance are high when compared with other European states. Therefore, the study aimed to describe the recent progression of nosocomial infections due to vancomycin-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Remschmidt, Cornelius, Schröder, Christin, Behnke, Michael, Gastmeier, Petra, Geffers, Christine, Kramer, Tobias Siegfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937822/
https://www.ncbi.nlm.nih.gov/pubmed/29760912
http://dx.doi.org/10.1186/s13756-018-0353-x
_version_ 1783320687033712640
author Remschmidt, Cornelius
Schröder, Christin
Behnke, Michael
Gastmeier, Petra
Geffers, Christine
Kramer, Tobias Siegfried
author_facet Remschmidt, Cornelius
Schröder, Christin
Behnke, Michael
Gastmeier, Petra
Geffers, Christine
Kramer, Tobias Siegfried
author_sort Remschmidt, Cornelius
collection PubMed
description BACKGROUND: Enterococci are frequent pathogens causing nosocomial infections in Germany. Infections due to strains with vancomycin resistance are high when compared with other European states. Therefore, the study aimed to describe the recent progression of nosocomial infections due to vancomycin-resistant enterococci (VRE) in Germany. METHODS: We analyzed data from two components of the German national nosocomial infection surveillance system for the period 2007–2016. For primary bloodstream infections (BSIs) and urinary tract infections (UTIs) we used data from intensive care units and for surgical site infections (SSIs) data from surgical departments. In a sensitivity analysis, we considered only data from participants that participated continuously from 2007 to 2016 (“core group”). We calculated proportions of VRE among all nosocomial enterococcal infections with 95% confidence intervals (95% CIs) and trends over time. A multivariable logistic regression was used to compare occurrence of VRE proportions among German federal states. RESULTS: Enterococcal infections from 857 ICUs and 1119 surgical departments were analyzed. On ICUs, the proportion of vancomycin resistance in enterococci causing nosocomial infections significantly increased for BSIs from 5.9 to 16.7% and for UTIs from 2.9 to 9.9%; for surgical site infections, the proportion of VRE increased from 0.9 to 5.2% (P < 0.001 for all). In the core group, the increase of VRE was more pronounced in ICUs (BSIs: 5.5 to 21.6%; UTIs: 2 to 11.2%) but was not seen in surgical departments (SSIs: 1.5 to 2.8%). Compared with the most populous German federal state North Rhine Westphalia, enterococcal infections in Hesse (Odds Ratio (OR) 2.3, 95% CI 1.7–3.1), Saxony (OR 2.5, 95% CI 1.8–3.5) and Thuringia (OR 1.9, 95% CI 1.4–2.6) were more likely to be caused by vancomycin-resistant strains. CONCLUSION: In Germany, the proportion of VRE in nosocomial infection due to enterococci is still increasing. It remains unclear, why a large variation in the proportion of VRE exists between German federal states.
format Online
Article
Text
id pubmed-5937822
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59378222018-05-14 Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance Remschmidt, Cornelius Schröder, Christin Behnke, Michael Gastmeier, Petra Geffers, Christine Kramer, Tobias Siegfried Antimicrob Resist Infect Control Research BACKGROUND: Enterococci are frequent pathogens causing nosocomial infections in Germany. Infections due to strains with vancomycin resistance are high when compared with other European states. Therefore, the study aimed to describe the recent progression of nosocomial infections due to vancomycin-resistant enterococci (VRE) in Germany. METHODS: We analyzed data from two components of the German national nosocomial infection surveillance system for the period 2007–2016. For primary bloodstream infections (BSIs) and urinary tract infections (UTIs) we used data from intensive care units and for surgical site infections (SSIs) data from surgical departments. In a sensitivity analysis, we considered only data from participants that participated continuously from 2007 to 2016 (“core group”). We calculated proportions of VRE among all nosocomial enterococcal infections with 95% confidence intervals (95% CIs) and trends over time. A multivariable logistic regression was used to compare occurrence of VRE proportions among German federal states. RESULTS: Enterococcal infections from 857 ICUs and 1119 surgical departments were analyzed. On ICUs, the proportion of vancomycin resistance in enterococci causing nosocomial infections significantly increased for BSIs from 5.9 to 16.7% and for UTIs from 2.9 to 9.9%; for surgical site infections, the proportion of VRE increased from 0.9 to 5.2% (P < 0.001 for all). In the core group, the increase of VRE was more pronounced in ICUs (BSIs: 5.5 to 21.6%; UTIs: 2 to 11.2%) but was not seen in surgical departments (SSIs: 1.5 to 2.8%). Compared with the most populous German federal state North Rhine Westphalia, enterococcal infections in Hesse (Odds Ratio (OR) 2.3, 95% CI 1.7–3.1), Saxony (OR 2.5, 95% CI 1.8–3.5) and Thuringia (OR 1.9, 95% CI 1.4–2.6) were more likely to be caused by vancomycin-resistant strains. CONCLUSION: In Germany, the proportion of VRE in nosocomial infection due to enterococci is still increasing. It remains unclear, why a large variation in the proportion of VRE exists between German federal states. BioMed Central 2018-04-24 /pmc/articles/PMC5937822/ /pubmed/29760912 http://dx.doi.org/10.1186/s13756-018-0353-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Remschmidt, Cornelius
Schröder, Christin
Behnke, Michael
Gastmeier, Petra
Geffers, Christine
Kramer, Tobias Siegfried
Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance
title Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance
title_full Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance
title_fullStr Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance
title_full_unstemmed Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance
title_short Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance
title_sort continuous increase of vancomycin resistance in enterococci causing nosocomial infections in germany − 10 years of surveillance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937822/
https://www.ncbi.nlm.nih.gov/pubmed/29760912
http://dx.doi.org/10.1186/s13756-018-0353-x
work_keys_str_mv AT remschmidtcornelius continuousincreaseofvancomycinresistanceinenterococcicausingnosocomialinfectionsingermany10yearsofsurveillance
AT schroderchristin continuousincreaseofvancomycinresistanceinenterococcicausingnosocomialinfectionsingermany10yearsofsurveillance
AT behnkemichael continuousincreaseofvancomycinresistanceinenterococcicausingnosocomialinfectionsingermany10yearsofsurveillance
AT gastmeierpetra continuousincreaseofvancomycinresistanceinenterococcicausingnosocomialinfectionsingermany10yearsofsurveillance
AT gefferschristine continuousincreaseofvancomycinresistanceinenterococcicausingnosocomialinfectionsingermany10yearsofsurveillance
AT kramertobiassiegfried continuousincreaseofvancomycinresistanceinenterococcicausingnosocomialinfectionsingermany10yearsofsurveillance